Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
NEWS PLX CELLS SELECTED FOR EUROPEAN MEDICINES PILOT PROJECT
Significant Progress for Pluristem: PLX Cells Were Selected for European Medicines Agency's Adaptive Pathways Pilot Project
Pluristem is Targeting Critical Limb Ischemia as the First Indication for Initial Marketing Authorization, Potentially Substantially Shortening the Time to Market of PLX Cells Via the Adaptive Pathways